000 | 01466 a2200421 4500 | ||
---|---|---|---|
005 | 20250514191648.0 | ||
264 | 0 | _c20040806 | |
008 | 200408s 0 0 eng d | ||
022 | _a0007-0920 | ||
024 | 7 |
_a10.1038/sj.bjc.6601895 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aKelly, J D | |
245 | 0 | 0 |
_aDownregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas. _h[electronic resource] |
260 |
_bBritish journal of cancer _cJul 2004 |
||
300 |
_a164-70 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aCarcinoma, Renal Cell _xmetabolism |
650 | 0 | 4 | _aDown-Regulation |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aInterferon-alpha _xpharmacology |
650 | 0 | 4 |
_aKidney Neoplasms _xmetabolism |
650 | 0 | 4 | _aOligonucleotides, Antisense |
650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xbiosynthesis |
650 | 0 | 4 |
_aThionucleotides _xpharmacology |
650 | 0 | 4 | _aTumor Cells, Cultured |
650 | 0 | 4 |
_afas Receptor _xpharmacology |
700 | 1 | _aDai, J | |
700 | 1 | _aEschwege, P | |
700 | 1 | _aGoldberg, J S | |
700 | 1 | _aDuggan, B P | |
700 | 1 | _aWilliamson, K E | |
700 | 1 | _aBander, N H | |
700 | 1 | _aNanus, D M | |
773 | 0 |
_tBritish journal of cancer _gvol. 91 _gno. 1 _gp. 164-70 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/sj.bjc.6601895 _zAvailable from publisher's website |
999 |
_c14894938 _d14894938 |